$SHMP
NaturalShrimp Inc Stock $shmp

$shmp Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000165495421009102 Filed on August 16, 2021

Income Statement

Concept	2021 Q3	2021 Q2	2020 Q2
Revenue	$0.00		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.183M	$1.884M	$347.4K
YoY Change	167.29%	442.27%	2.73%
% of Gross Profit
Research & Development	$196.9K		$0.00
YoY Change	147.48%
% of Gross Profit
Depreciation & Amortization	$404.3K	$355.0K	$10.78K
YoY Change	4442.47%	3192.83%	-11.92%
% of Gross Profit
Operating Expenses	$2.784M	$2.238M	$358.1K
YoY Change	399.15%	524.93%	2.22%
Operating Profit	-$2.784M	-$2.238M	-$358.1K
YoY Change	399.15%	524.93%
Interest Expense	$65.66K	$81.54K	$30.03K
YoY Change	122.66%	171.55%	-108.6%
% of Operating Profit
Other Income/Expense, Net	-$65.66K	-$324.7K	$120.8K
YoY Change	104.35%	-368.67%	-341.67%
Pretax Income	-$2.850M	-$2.563M	-$479.0K
YoY Change	383.09%	435.06%	-36.09%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$2.850M	-$2.563M	-$479.0K
YoY Change	384.47%	435.06%	-36.09%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00	-$0.02
Diluted Earnings Per Share	-$4.720K	-$5.110K	-$1.235K
COMMON SHARES
Basic Shares Outstanding	603.0M shares	501.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q3	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$800.5K	$5.973M	$1.113M
YoY Change	153.65%	436.76%	36.0%
Cash & Equivalents	$800.5K	$5.973M	$1.113M
Short-Term Investments
Other Short-Term Assets	$287.1K	$578.8K	$59.95K
YoY Change	86.26%	865.54%	9.14%
Inventory
Prepaid Expenses	$287.1K	$578.8K
Receivables
Other Receivables
Total Short-Term Assets	$1.088M	$6.551M	$1.173M
YoY Change	131.54%	458.68%	33.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.27M	$12.34M	$1.099M
YoY Change	240.63%	1023.47%	-48.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$21.13M	$9.595M	$807.1K
YoY Change	102314.0%	1088.79%	3812.17%
Total Long-Term Assets	$33.40M	$21.94M	$1.906M
YoY Change	821.89%	1051.14%	-10.85%
TOTAL ASSETS
Total Short-Term Assets	$1.088M	$6.551M	$1.173M
Total Long-Term Assets	$33.40M	$21.94M	$1.906M
Total Assets	$34.49M	$28.49M	$3.078M
YoY Change	742.65%	825.45%	2.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.822M	$656.2K	$492.0K
YoY Change	372.02%	33.38%	-13.19%
Accrued Expenses	$544.0K	$568.5K	$881.4K
YoY Change	-0.94%	-35.5%	-12.16%
Deferred Revenue
YoY Change
Short-Term Debt	$515.5K	$516.3K	$1.792M
YoY Change	-71.76%	-71.19%	-8.54%
Long-Term Debt Due	$106.4K	$104.7K	$390.2K
YoY Change	-61.96%	-73.16%	-62.54%
Total Short-Term Liabilities	$6.208M	$2.107M	$3.644M
YoY Change	74.49%	-42.19%	-24.17%
LONG-TERM LIABILITIES
Long-Term Debt	$5.368M	$5.396M	$221.8K
YoY Change	1032.22%	2333.12%
Other Long-Term Liabilities	$321.3K	$0.00	$275.4K
YoY Change	16.68%	-100.0%	0.0%
Total Long-Term Liabilities	$5.689M	$5.396M	$497.2K
YoY Change	659.07%	985.3%	80.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.208M	$2.107M	$3.644M
Total Long-Term Liabilities	$5.689M	$5.396M	$497.2K
Total Liabilities	$11.90M	$7.502M	$4.057M
YoY Change	181.81%	84.93%	-20.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$67.41M	$62.86M
YoY Change
Common Stock	$60.68K	$60.27K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.21M	$18.95M	-$1.062M
YoY Change
Total Liabilities & Shareholders Equity	$34.49M	$28.49M	$3.078M
YoY Change	742.65%	825.45%	2.05%

Cashflow Statement

Concept	2021 Q3	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$2.850M	-$2.563M	-$479.0K
YoY Change	384.47%	435.06%	-36.09%
Depreciation, Depletion And Amortization	$404.3K	$355.0K	$10.78K
YoY Change	4442.47%	3192.83%	-11.92%
Cash From Operating Activities	-$2.013M	-$2.141M	-$1.187M
YoY Change	-699.12%	80.35%	151.5%
INVESTING ACTIVITIES
Capital Expenditures	-$782.6K	$411.3K	$126.2K
YoY Change	-66.77%	226.01%	-142.39%
Acquisitions		$2.000M	$0.00
YoY Change
Other Investing Activities	-$2.350M	-$1.000M	$917.2K
YoY Change		-209.03%
Cash From Investing Activities	-$3.133M	-$4.161M	$791.1K
YoY Change	33.02%	-626.0%	-365.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$17.28M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-26.86K	$12.12M	$1.399M
YoY Change	-102.2%	766.1%	-6.47%
NET CHANGE
Cash From Operating Activities	-2.013M	-$2.141M	-$1.187M
Cash From Investing Activities	-3.133M	-$4.161M	$791.1K
Cash From Financing Activities	-26.86K	$12.12M	$1.399M
Net Change In Cash	-5.172M	$5.817M	$1.003M
YoY Change	548.85%	479.81%	38.1%
FREE CASH FLOW
Cash From Operating Activities	-$2.013M	-$2.141M	-$1.187M
Capital Expenditures	-$782.6K	$411.3K	$126.2K
Free Cash Flow	-$1.230M	-$2.552M	-$1.313M
YoY Change	-145.71%	94.34%	653.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	603019728	shares
CY2021Q2	us-gaap	Cash Cash	5972617	USD
CY2021Q1	us-gaap	Cash Cash	155795	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	578839	USD
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	655339	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	6551456	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	811134	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12342347	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12236557	USD
CY2021Q2	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	2622870	USD
CY2021Q1	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1873219	USD
CY2021Q2	shmp	Patents Patents	6951000	USD
CY2021Q1	shmp	Patents Patents	0	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	275400	USD
CY2021Q2	us-gaap	Deposits Assets DepositsAssets	20633	USD
CY2021Q1	us-gaap	Deposits Assets DepositsAssets	20633	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9594503	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2169252	USD
CY2021Q1	us-gaap	Liabilities Liabilities	10122642	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2106522	USD
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	96000	USD
CY2021Q2	shmp	Notes Payable Related Parties NotesPayableRelatedParties	495412	USD
CY2021Q1	shmp	Notes Payable Related Parties NotesPayableRelatedParties	1151162	USD
CY2021Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	0	USD
CY2021Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	182639	USD
CY2021Q2	us-gaap	Assets Assets	28488306	USD
CY2021Q1	us-gaap	Assets Assets	15216943	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	656150	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	963289	USD
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	73350	USD
CY2021Q1	us-gaap	Interest Payable Current InterestPayableCurrent	73350	USD
CY2021Q2	shmp	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	187520	USD
CY2021Q1	shmp	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	187520	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	568532	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	602368	USD
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	20833	USD
CY2021Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	573621	USD
CY2021Q2	us-gaap	Loans Payable To Bank LoansPayableToBank	8725	USD
CY2021Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	8725	USD
CY2021Q2	us-gaap	Loans Payable Current LoansPayableCurrent	0	USD
CY2021Q1	us-gaap	Loans Payable Current LoansPayableCurrent	103200	USD
CY2021Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2021Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	483637	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	96000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4425511	USD
CY2021Q2	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	204085	USD
CY2021Q1	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	206127	USD
CY2021Q2	shmp	Note Payables NotePayables	5000000	USD
CY2021Q1	shmp	Note Payables NotePayables	5000000	USD
CY2021Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	191604	USD
CY2021Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	215604	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	275400	USD
CY2021Q2	us-gaap	Liabilities Liabilities	7502211	USD
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	603019728	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	560745180	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	602644728	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	560745180	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	60266	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	56075	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	74585336	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56649491	USD
CY2021Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	7160900	USD
CY2021Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	136000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	62856334	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	53683268	USD
CY2021Q2	shmp	Total Stockholders Deficit Attributable To Naturalshrimp Incorporated Shareholders TotalStockholdersDeficitAttributableToNaturalshrimpIncorporatedShareholders	18950668	USD
CY2021Q1	shmp	Total Stockholders Deficit Attributable To Naturalshrimp Incorporated Shareholders TotalStockholdersDeficitAttributableToNaturalshrimpIncorporatedShareholders	3158798	USD
CY2021Q2	us-gaap	Members Equity Attributable To Noncontrolling Interest MembersEquityAttributableToNoncontrollingInterest	0	USD
CY2021Q1	us-gaap	Members Equity Attributable To Noncontrolling Interest MembersEquityAttributableToNoncontrollingInterest	-87830	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2562743	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18950668	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3070968	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28488306	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	358132	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2238090	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-358132	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	81536	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	30026	USD
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	236364	USD
CY2020Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2020Q2	shmp	Gain Loss On Warrant Liabilities Net Pretax GainLossOnWarrantLiabilitiesNetPretax	0	USD
CY2021Q2	shmp	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	103200	USD
CY2020Q2	shmp	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	0	USD
CY2021Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2020Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2021Q2	us-gaap	Loss From Catastrophes LossFromCatastrophes	0	USD
CY2020Q2	us-gaap	Loss From Catastrophes LossFromCatastrophes	0	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	324653	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	120835	USD
CY2021Q2	shmp	Financing Costs FinancingCosts	-109953	USD
CY2020Q2	shmp	Financing Costs FinancingCosts	-61809	USD
CY2021Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2020Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-29000	USD
CY2021Q2	shmp	Gain Loss On Warrant Liabilities Net Pretax GainLossOnWarrantLiabilitiesNetPretax	0	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15216943	USD
CY2021Q2	us-gaap	Revenues Revenues	0	USD
CY2020Q2	us-gaap	Revenues Revenues	0	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1644262	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	335979	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	USD
CY2021Q2	us-gaap	Facility Costs FacilityCosts	239325	USD
CY2020Q2	us-gaap	Facility Costs FacilityCosts	11372	USD
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	354503	USD
CY2020Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10781	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2238090	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-478967	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2562743	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-478967	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1895	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2562743	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-477072	USD
CY2021Q2	shmp	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-817376	USD
CY2020Q2	shmp	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-293000	USD
CY2020Q2	us-gaap	Accretion Expense AccretionExpense	0	USD
CY2021Q2	shmp	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares	-5792947	USD
CY2020Q2	shmp	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares	0	USD
CY2020Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	144792	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9173066	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-914864	USD
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	501477593	shares
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	386434991	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	3070969	USD
CY2021Q2	shmp	Issuance Of Common Share Upon Conversion Amount IssuanceOfCommonShareUponConversionAmount	421486	USD
CY2021Q2	shmp	Conversion Of Series B Ps To Common Stock Amount ConversionOfSeriesBPsToCommonStockAmount	0	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	USD
CY2021Q2	shmp	Exchange Of Series D Ps To Series E Ps ExchangeOfSeriesDPsToSeriesEPs	-3258189	USD
CY2021Q2	shmp	Sale Of Common Shares And Warrants For Cash Less Offering Costs And Commitment Shares Amount SaleOfCommonSharesAndWarrantsForCashLessOfferingCostsAndCommitmentSharesAmount	17277223	USD
CY2021Q2	shmp	Exercise Of Warrants Related To The Sale Of Common Shares Amount ExerciseOfWarrantsRelatedToTheSaleOfCommonSharesAmount	11000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3269505	USD
CY2021Q2	shmp	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-817376	USD
CY2021Q2	shmp	Redemption Of Series D Preferred Shares RedemptionOfSeriesDPreferredShares	-2534758	USD
CY2021Q2	shmp	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	0	USD
CY2021Q2	shmp	Commitment Shares Issued With Series D Preferred Shares CommitmentSharesIssuedWithSeriesDPreferredShares	0	USD
CY2021Q2	shmp	Common Shares To Be Issued For The Acquisition Of The Non Controlling Interest Subsidiarys Remaining Equity CommonSharesToBeIssuedForTheAcquisitionOfTheNonControllingInterestSubsidiarysRemainingEquity	-1000000	USD
CY2021Q2	shmp	Common Shares To Be Issued For Patent Acquisition CommonSharesToBeIssuedForPatentAcquisition	5000000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	73651	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2562743	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	18950768	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-2937780	USD
CY2020Q2	shmp	Issuance Of Common Share Upon Conversion Amount IssuanceOfCommonShareUponConversionAmount	226437	USD
CY2020Q2	us-gaap	Prior Period Reclassification Adjustment PriorPeriodReclassificationAdjustment	205000	USD
CY2020Q2	shmp	Series B Preferred Stock Issued During Period Value New Issues SeriesBPreferredStockIssuedDuringPeriodValueNewIssues	1250000	USD
CY2020Q2	shmp	Dividends Payable On Series B Ps DividendsPayableOnSeriesBPs	-144792	USD
CY2020Q2	shmp	Series B Ps Dividends In Kind Issued Amount SeriesBPsDividendsInKindIssuedAmount	56458	USD
CY2020Q2	shmp	Common Stock Issued In Vista Warrant Settlement Amount CommonStockIssuedInVistaWarrantSettlementAmount	610000	USD
CY2020Q2	shmp	Prior Period Reclassification Adjustment Other PriorPeriodReclassificationAdjustmentOther	90000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	61250	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-477072	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-1060499	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2562743	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-477072	USD
CY2021Q2	us-gaap	Depreciation Depreciation	354503	USD
CY2020Q2	us-gaap	Depreciation Depreciation	10781	USD
CY2021Q2	shmp	Amortization Of Debt Discount AmortizationOfDebtDiscount	236364	USD
CY2020Q2	shmp	Amortization Of Debt Discount AmortizationOfDebtDiscount	0	USD
CY2021Q2	shmp	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	0	USD
CY2020Q2	shmp	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	29000	USD
CY2021Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	109953	USD
CY2020Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2020Q2	shmp	Default Penalty DefaultPenalty	41112	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1895	USD
CY2021Q2	shmp	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	103200	USD
CY2020Q2	shmp	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	0	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	73651	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	61250	USD
CY2021Q2	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	76500	USD
CY2020Q2	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	68743	USD
CY2021Q2	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	0	USD
CY2020Q2	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	-628879	USD
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-304997	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-149193	USD
CY2021Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-33836	USD
CY2020Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-159814	USD
CY2021Q2	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	13018	USD
CY2020Q2	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	6836	USD
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	0	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	12096	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2140788	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1187035	USD
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	411293	USD
CY2020Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	126158	USD
CY2021Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2000000	USD
CY2020Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q2	shmp	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci	1000000	USD
CY2020Q2	shmp	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci	0	USD
CY2021Q2	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	USD
CY2020Q2	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	917210	USD
CY2021Q2	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	749651	USD
CY2020Q2	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	0	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4160944	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	791052	USD
CY2021Q2	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	2042	USD
CY2020Q2	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	3989	USD
CY2021Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	24000	USD
CY2020Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2021Q2	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	655750	USD
CY2020Q2	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2021Q2	shmp	Repayment Of Short Term Promissory Note And Lines Of Credit RepaymentOfShortTermPromissoryNoteAndLinesOfCredit	552788	USD
CY2020Q2	shmp	Repayment Of Short Term Promissory Note And Lines Of Credit RepaymentOfShortTermPromissoryNoteAndLinesOfCredit	0	USD
CY2021Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2020Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	103200	USD
CY2021Q2	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	17277223	USD
CY2020Q2	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	0	USD
CY2021Q2	shmp	Shares Issued Upon Exercise Of Warrants SharesIssuedUponExerciseOfWarrants	11000	USD
CY2020Q2	shmp	Shares Issued Upon Exercise Of Warrants SharesIssuedUponExerciseOfWarrants	0	USD
CY2021Q2	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2020Q2	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1250000	USD
CY2021Q2	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	421486	USD
CY2020Q2	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2021Q2	shmp	Redemption Of Series D Ps RedemptionOfSeriesDPs	-3513504	USD
CY2020Q2	shmp	Redemption Of Series D Ps RedemptionOfSeriesDPs	0	USD
CY2021Q2	shmp	Proceeds From Issuance Of Preferred Stock And Preference Stock Other ProceedsFromIssuanceOfPreferredStockAndPreferenceStockOther	0	USD
CY2020Q2	shmp	Proceeds From Issuance Of Preferred Stock And Preference Stock Other ProceedsFromIssuanceOfPreferredStockAndPreferenceStockOther	0	USD
CY2021Q2	shmp	Cash Received From Warrant Settlement CashReceivedFromWarrantSettlement	0	USD
CY2020Q2	shmp	Cash Received From Warrant Settlement CashReceivedFromWarrantSettlement	50000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12118653	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1399211	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5816922	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1003228	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	155795	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109491	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5972717	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1112719	USD
CY2021Q2	us-gaap	Interest Paid Net InterestPaidNet	81536	USD
CY2020Q2	us-gaap	Interest Paid Net InterestPaidNet	17930	USD
CY2021Q2	shmp	Shares Issued Upon Conversion SharesIssuedUponConversion	421486	USD
CY2020Q2	shmp	Shares Issued Upon Conversion SharesIssuedUponConversion	226437	USD
CY2021Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	275400	USD
CY2020Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q2	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	0	USD
CY2020Q2	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	56458	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	560000	USD
CY2021Q2	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021Q2	shmp	Shares To Be Issued As Consideration For Patent Acquisition SharesToBeIssuedAsConsiderationForPatentAcquisition	5000000	USD
CY2020Q2	shmp	Shares To Be Issued As Consideration For Patent Acquisition SharesToBeIssuedAsConsiderationForPatentAcquisition	0	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2000000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2021Q2	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – NATURE OF THE ORGANIZATION AND BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Nature of the Business</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">NaturalShrimp Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a biotechnology company and has developed a proprietary technology that allows it to grow Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density, low-cost environment, and in fully contained and independent production facilities. The Company’s system uses technology which allows it to produce a naturally-grown shrimp “crop” weekly and accomplishes this without the use of antibiotics or toxic chemicals. The Company has developed several proprietary technology assets, including a knowledge base that allows it to produce commercial quantities of shrimp in a closed system with a computer monitoring system that automates, monitors and maintains proper levels of oxygen, salinity and temperature for optimal shrimp production. Its initial production facility is located outside of San Antonio, Texas.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">On December 15, 2020, the Company entered into an Asset Purchase Agreement (“APA”) between VeroBlue Farms USA, Inc., a Nevada corporation (“VBF”), VBF Transport, Inc., a Delaware corporation (“Transport”), and Iowa’s First, Inc., an Iowa corporation (“Iowa’s First”) (each a “Seller” and collectively, “Sellers”). Transport and Iowa’s First were wholly-owned subsidiaries of VBF. The agreement called for the Company to purchase all of the tangible assets of VBF, the motor vehicles of Transport and the real property (together with all plants, buildings, structures, fixtures, fittings, systems and other improvements located on such real property) of Iowa’s First. The facility was originally designed as an aquaculture facility, with the company having production issues. The Company began a modification process to convert the plant to produce shrimp, which will allow them to scale faster without having to build new facilities. The three Iowa facilities contain the tanks and infrastructure that will be used to support the production of shrimp with the incorporation of the Company's patented EC platform technology. On May 19, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with F&T Water Solutions, LLC (“F&T”), for F&T’s owned shares of Natural Aquatic Systems, Inc. Prior to entering into the SPA, the Company owned fifty-one percent (51%) and F&T owned forty-nine percent (49%) of the issued and outstanding shares of common stock of NAS. After the SPA, NAS is a 100% owned subsidiary of the Company (See Note 8).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The Company has three wholly-owned subsidiaries including NaturalShrimp Corporation, NaturalShrimp Global, Inc. and NAS.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Going Concern</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the three months ended June 30, 2021, the Company had a net loss available for common stockholders of approximately $9,173,000. At June 30, 2021, the Company had an accumulated deficit of approximately $62,856,000. These factors raise substantial doubt about the Company’s ability to continue as a going concern, within one year from the issuance date of this filing. The Company’s ability to continue as a going concern is dependent on its ability to raise the required additional capital or debt financing to meet short and long-term operating requirements. During the three months ended June 30, 2021, the Company received net cash proceeds of approximately $17,277,000 from the sale of common shares (See Note 9). Management believes that private placements of equity capital will be needed to fund the Company’s long-term operating requirements. The Company may also encounter business endeavors that require significant cash commitments or unanticipated problems or expenses that could result in a requirement for additional cash. If the Company raises additional funds through the issuance of equity, the percentage ownership of its current shareholders could be reduced, and such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict our operations. The Company continues to pursue external financing alternatives to improve its working capital position. If the Company is unable to obtain the necessary capital, the Company may be unable to develop its facilities and enter in production.</p>
CY2021Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1560000	shares
CY2021Q2	shmp	Derivative Liability Ending DerivativeLiabilityEnding	176000	USD
CY2021Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	-205000	USD
CY2021Q2	shmp	Change In Fair Value ChangeInFairValue	29000	USD
CY2021Q2	shmp	Balance At End Of Period BalanceAtEndOfPeriod	0	USD
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	90000	USD
CY2021Q2	shmp	Warrant Liability Reclass To Equity Upon Exercise WarrantLiabilityReclassToEquityUponExercise	-90000	USD
CY2021Q2	shmp	Gain Loss On Warrant Liability GainLossOnWarrantLiability	0	USD
CY2021Q2	shmp	Warrant Liability Ending WarrantLiabilityEnding	0	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12236557	USD
CY2020Q2	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	11000	USD
CY2021Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The Company maintains cash balances at two financial institutions. Accounts at this institution are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. As of June 30, 2021 the Company’s cash balance exceeded FDIC coverage. As of March 31, 2021, the Company’s cash balance did not exceed FDIC coverage. The Company has not experienced any losses in such accounts and periodically evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.</p>
CY2021Q2	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	306000	USD
CY2021Q2	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	789	USD
CY2016Q1	shmp	Consulting Services ConsultingServices	655750	USD
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	USD
CY2021Q2	shmp	Borrowing Rate BorrowingRate	5%
CY2020Q3	shmp	Promissory Note For Accrued Compensation And Debt PromissoryNoteForAccruedCompensationAndDebt	383604	USD
CY2021Q2	shmp	Monthly Rent MonthlyRent	7000	USD
CY2021Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1727	USD
CY2021Q2	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	52362	USD
CY2021Q2	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	17454	USD

Files In Submission

Name	View Source	Status
0001654954-21-009102-index-headers.html	Edgar Link	pending
0001654954-21-009102-index.html	Edgar Link	pending
0001654954-21-009102.txt	Edgar Link	pending
0001654954-21-009102-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shmp-20210630.xsd	Edgar Link	pending
shmp-20210630_cal.xml	Edgar Link	unprocessable
shmp-20210630_def.xml	Edgar Link	unprocessable
shmp-20210630_lab.xml	Edgar Link	unprocessable
shmp-20210630_pre.xml	Edgar Link	unprocessable
shmp_10q.htm	Edgar Link	pending
shmp_10q_htm.xml	Edgar Link	completed
shmp_ex311.htm	Edgar Link	pending
shmp_ex312.htm	Edgar Link	pending
shmp_ex321.htm	Edgar Link	pending
shmp_ex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHMP
NaturalShrimp Inc Stock $shmp

2021 Q3 Form 10-Q Financial Statement

#000165495421009102 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP NaturalShrimp Inc Stock $shmp

2021 Q3 Form 10-Q Financial Statement

#000165495421009102 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP
NaturalShrimp Inc Stock $shmp